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Introduction
Despite significant progress in our understanding of both G protein-coupled receptor (GPCR) function and the neurobiology of psychiatric disease, psychopharmacology remains frustratingly opaque, fraught with more questions than answers. A major reason for these continued struggles can be found in the fact that many psychopharmacological agents are prototypical "dirty drugs" interacting with numerous molecular targets, including, but not limited to, many GPCRs (Meyer, 2011) . The molecular promiscuity of these drugs makes it extremely difficult to develop a coherent working model for their therapeutic mechanisms of action. Progress on this front therefore requires careful investigation of the pharmacological actions these drugs exert at their various binding partners. In the present era of molecular pharmacology, with its explosion in knowledge regarding GPCR structural determination and modeling (Kobilka, 2011; Shoichet and Kobilka, 2012; Costanzi, 2014) , such investigation can and should include structural probing in addition to classic in vitro and in vivo pharmacological techniques.
Psychopharmacological agents belonging to the tricyclic chemical class are particularly noted for their molecular promiscuity (Baldessarini, 2006; Meyer, 2011) , and thus represent a particularly challenging yet interesting group for study. This class comprises both antidepressant therapeutics used primarily in the pharmacological management of depressive disorders and antipsychotic therapeutics used primarily in the pharmacological management of schizophrenia. In recent years, we have completed extensive studies regarding the tricyclic antidepressant (TCA) compounds, including desipramine (DMI), imipramine, and amitriptyline, with a focus on characterizing novel actions of DMI as a direct ligand at the a 2A adrenergic receptor (AR) (Cottingham et al., 2011 (Cottingham et al., , 2012a (Cottingham et al., ,b, 2014 . The a 2A AR has long been appreciated as the predominant a 2 AR subtype expressed throughout the central nervous system (De Vos et al., 1992; Sastre and García-Sevilla, 1994; Wang et al., 1996) , is intimately involved in the function of the brain noradrenergic system, and has been shown to be dysregulated in certain psychiatric disorders .
Our previous work has uncovered the novel finding that TCAs function as arrestin-biased ligands at the a 2A AR, selectively recruiting the non-visual arrestins (arrestin2/3, also known as barrestin1/2) to the a 2A AR while not activating any detectable signal transduction through heterotrimeric G proteins (Cottingham et al., 2011 (Cottingham et al., , 2014 . This arrestin recruitment leads to classical arrestinand clathrin-mediated GPCR endocytosis with acute exposure. Such arrestin-biased agonism linking to receptor internalization raises the possibility that these compounds could impact the dynamic molecular balance within complex CNS synapses (Molinoff, 2011) by initiating endocytosis and altering the cell-surface availability (von Zastrow and Williams, 2012; Irannejad et al., 2015) of a 2A ARs.
Although arrestin-biased agonism of GPCRs generally has been established in the field for many years now (Violin and Lefkowitz, 2007; Rajagopal et al., 2010) , our work provided the first evidence for this phenomenon at the a 2A AR specifically. Currently, it is unclear whether any of the tricyclic antipsychotics share the properties of the TCAs as direct arrestin-biased a 2A AR ligands. In the present study, we have therefore set out to characterize representative tricyclic antipsychotic compounds as direct a 2A AR ligands. Our data indicate that, while all tricyclics studied can interact with the a 2A AR at physiologically-relevant affinity values, these compounds exhibit widely varying functional profiles as a 2A AR ligands, especially with respect to arrestin3 (Arr3) recruitment and the induction of receptor endocytosis. Additionally, in silico molecular modeling suggests that differences exist in how the compounds studied interact with the a 2A AR ligand-binding site.
These findings are of great value, as they highlight the mechanistic differences between chemically-similar antidepressants and antipsychotics, and have the potential to inform the development of next-generation agents with improved pharmacological precision.
Materials & methods

Drugs
All pharmacological agents, with the exception of clozapine, were purchased from Sigma-Aldrich. These agents were supplied in the following forms: chlorpromazine HCl, fluphenazine diHCl, norepinephrine (NE) bitartrate salt, prazosin HCl, propranolol HCl. Clozapine was obtained from the National Institute of Mental Health Chemical Synthesis and Drug Supply Program, supplied in an unmodified chemical form. Concentrated stock solutions of all agents were prepared by dissolving in water, with the exception of clozapine, which was initially dissolved in DMSO before dilution in water.
Cell culture
Heterologous cell lines stably expressing an N-terminal hemagglutinin (HA) epitope-tagged murine a 2A AR were used for all experiments. The generation and characterization of the HEK 293 (Schramm and Limbird, 1999) and both the wild-type (WT) and arrestin-null (Arr2,3 -/-) mouse embryonic fibroblast (MEF) stable cell lines (Brady et al., 2005; Cottingham et al., 2011) has been described previously. The HEK 293 line expresses HA-a 2A ARs at a density of 7e8 pmol/mg (Schramm and Limbird, 1999) , while the MEF lines express HA-a 2A ARs at a density of 400 fmol/mg (Cottingham et al., 2011) . All three cell lines were cultured in Dulbecco's modified Eagle medium (DMEM, Life Technologies) supplemented with 10% fetal bovine serum (Atlanta Biologicals) and 1% penicillin/streptomycin (Life Technologies), and maintained at 37 C in a humidified 5% CO 2 incubator.
Radioligand binding
Binding of the various drugs to the a 2A AR was assessed by competition for binding with a 3 H-labeled a 2 AR antagonist ([ 3 H] RX821002, PerkinElmer). All radioligand binding experiments were done in crude membrane preparations from the stable HEK 293 cell line, and in the presence of Gpp(NH)p to eliminate binding regulation by heterotrimeric G proteins, as previously described Lu et al., 2009; Cottingham et al., 2011) . Determination of orthosteric site binding was performed according to a method described by Limbird (2005) and utilized in our previous study on DMI (Cottingham et al., 2011) . Concentrationresponse curves were constructed and K i values determined by GraphPad Prism software (GraphPad Software, San Diego, CA). Software-determined K i values were confirmed by hand calculation according to the method of Cheng and Prusoff/Chou (Cheng and Prusoff, 1973; Chou, 1974) , utilizing the equation
. Saturation binding was performed to assess receptor density following prolonged treatments with various ligands as we have described previously (Lu et al., 2009; Cottingham et al., 2011) . Raw radioligand binding values were normalized to total protein content in each reaction.
[
S]GTPgS binding
Ligand-stimulated coupling of heterotrimeric G proteins to the a 2A AR was assessed by measuring [ 35 S]GTPgS binding to crude membrane preparations from the stable HEK 293 cell line as previously described (Tan et al., 2002; Cottingham et al., 2011) . [ 35 S] GTPgS (PerkinElmer) was used at a concentration of 320 pM (1250 Ci/mmol) per reaction tube. Ligand-stimulated G protein coupling was calculated as a fold increase in binding over no-ligand control reactions.
Western blot
The WT MEF cell line with stable HA-a 2A AR expression described above was utilized to assess clozapine-stimulated a 2A ARmediated activation of the ERK1/2 MAP kinase pathway via Western blot targeting phospho-ERK1/2 (pERK1/2). Western blot was carried out as previously described (Cottingham et al., 2011; Cottingham et al., 2012a,b) . Primary antibodies were phosphop44/42 MAPK (ERK1/2, Thr202/Tyr204) mouse mAb (Cell Signaling), total p44/42 MAPK (ERK1/2) rabbit polyclonal (Cell Signaling), with HRP-conjugated anti-mouse and anti-rabbit IgGs obtained from Millipore. Membranes were first probed for phospho-ERK1/2, then stripped and re-probed for total ERK1/2.
FLIM-FRET
Fluorescence lifetime imaging microscopy (FLIM) was the technique used to observe a 2A AR/Arr3 interaction in the form of FRET. Our method for performing FLIM-FRET to detect interaction between CFP-tagged a 2A ARs and YFP-tagged Arr3, as well as the generation of CFP-a 2A AR and YFP-Arr3 constructs, has been described previously in detail (Cottingham et al., 2011 Fig. 4B , C, 5 and 6 individual cells from 2 to 3 different transfected samples were subjected to FLIM, with a raw CFP lifetime value (in picoseconds) obtained. These raw lifetime values (t CFP for CFP-only cells and t FRET for CFP/YFP-expressing cells) were then used to calculate FLIM-FRET efficiency (E) values, according to the formula E ¼ 1 e (t FRET /t CFP ).
Intact cell-surface ELISA
Ligand-stimulated a 2A AR endocytosis was assessed quantitatively in MEF cells using a previously described method (Brady et al., 2003; Xu et al., 2008; Cottingham et al., 2011) for intact cell-surface ELISA. MEF cells were seeded onto 96-well culture plates at a density of 1 Â 10 4 cells/well, the primary anti-HA antibody (HA11, mouse monoclonal, Covance) was used at a final dilution of 1:3000, and the secondary antibody (anti-mouse HRPconjugated IgG, Millipore) was used at a final dilution of 1:2000. Endocytosis was measured as a percent decrease in cell-surface density from no-ligand control wells.
cAMP assay
cAMP assays were performed using the AlphaScreen ® Assay Kit (PerkinElmer) as previously described (Chen et al., 2012) . Briefly, cultured HEK 293 cells stably expressing the a 2A AR (Tan et al., 2002; Cottingham et al., 2011) were resuspended with the stimulation buffer (1Â HBSS, 0.1% BSA, 0.5 mM IBMX, 5 mM HEPES, pH 7.4) and mixed with anti-cAMP acceptor beads. The mix was divided into 3 groups and incubated at 37 C with the following chemicals: (1) vehicle; (2) 10 mM forskolin (Sigma); (3) 10 mM forskolin and ligand of interest. After a 20-min treatment, biotinylated cAMP/streptavidin donor beads (in 0.1% BSA, 0.3% Tween-20, 5 mM HEPES, pH 7.4) were added to the mix and incubated for an additional 30 min at room temperature. Fluorescence intensity was then analyzed on a Biotek Synergy2 plate reader.
Immunofluorescent staining
Ligand-stimulated a 2A AR endocytosis was assessed qualitatively in MEF cells using a primary antibody pre-labeling method for staining of HA-a 2A ARs that has been well-described previously (Xu et al., 2008; Lu et al., 2009 ). MEF cells were seeded onto glass cover slips in 24-well culture plates at a density of 2 Â 10 4 cells/well.
Surface a 2A ARs were pre-labeled with HA11 (1:125 dilution) prior to stimulation, with secondary antibody (Alexa488-conjugated anti-mouse IgG, Molecular Probes) used at a 1:1000 dilution to detect pre-labeled receptors after stimulation. Stained cells were visualized by confocal microscopy on a Zeiss LSM 710 (Carl Zeiss) or a Nikon A1 confocal microscope. Confocal images were analyzed using imaging software NIS-Elements AR4.13.00. The degree of colocalization between two proteins was quantified by Pearson's correlation coefficient using NIS-Elements AR4.13.00 subprogram Analysis Control-Colocalization.
K þ and cholesterol depletion protocols
A K þ depletion protocol for blocking formation of clathrincoated pits was performed as previously described on the ArrWT MEF cell line (Cottingham et al., 2011) . This method was used in conjunction with intact cell-surface ELISA to determine the clathrin-dependence of ligand-stimulated a 2A AR endocytosis.
Control cells received a sham treatment to allow for direct comparison with K þ -depleted cells. Control and K þ -depleted cells were analyzed via intact cell-surface ELISA (see above) in parallel, on the same 96-well plate.
Cholesterol depletion was achieved by treatment of cells with methyl-b-cyclodextrin (MbCD, Sigma-Aldrich). Specifically, cells were pre-treated with 10 mM MbCD (diluted to the final concentration in serum-free DMEM) for 30 min at 37 C prior to a trafficking experiment; 10 mM MbCD was then maintained throughout the experiment. Control cells simply received serum-free DMEM instead; both control and MbCD-treated cells were analyzed in parallel for each experiment via intact cell-surface ELISA or immunofluorescent staining (see above).
Molecular modeling
Structural model generation and molecular docking studies were conducted using the programs of the Schr€ odinger Suite 2014 (Schr€ odinger, LLC, New York, NY). A human a 2A AR homology model was built based on the crystal structure of the b 2 AR (PDB ID: 3PDS) using the Prime program (Prime, version 1.6, 2007). The 3D structures of ligands were prepared using the LigPrep program (LigPrep, version 2.3, 2009 ). The Glide program (Glide, version 6.3, 2014) was used for docking studies. Specifically, the Induced-Fit-Docking (IFD) protocol (Sherman et al., 2006) , which is capable of sampling dramatic side-chain conformational changes as well as minor changes in protein backbone structure, was applied to explore the binding mode of despiramine, chlorpromazine, clozapine and fluphenazine. NE was also docked as a control for comparison. Compounds were docked into the substrate binding site of the a 2A AR structural model. Residues within 5 Å of the docked compound were allowed to be flexible and the docked results were scored using the extraprecision (XP) mode of Glide. The best scored binding pose of each compound was select for the comparison of protein-ligand interactions. Residue numbers were based on Ballesteros Weinstein sequencing (Ballesteros and Weinstein, 1995) .
Software & statistical analysis
Representative chemical structures for the tricyclic agents were prepared using ChemDraw software (CambridgeSoft). Dose response curves and other graphs were constructed using GraphPad Prism (GraphPad Software), which was also used to calculate K i values and perform statistical tests.
Results
Tricyclic antipsychotic compounds bind to the a 2A AR at the orthosteric site
Three representative members of the tricyclic antipsychotic chemical class were selected for characterization as a 2A AR ligands: chlorpromazine, clozapine, and fluphenazine. Of those selected, two (chlorpromazine and fluphenazine) are typical, or firstgeneration, antipsychotics, while one (clozapine) is an atypical, or second-generation, antipsychotic (Meyer, 2011) . All of these compounds share a common tricyclic core structure with a characteristic long side chain (or fragment) arising from the central ring; the compounds vary slightly in central ring structure and small substituent identity, and radically in the nature of the characteristic long side chain (Fig. 1A) . Our first goal was to utilize competition radioligand binding analysis to determine accurate affinity (K i ) values for the selected antipsychotics at the murine HA-a 2A AR in membrane preparations from our HEK 293 cell line with stable expression of the receptor. Although initial results indicated that the antipsychotics were competing with the radiolabeled a 2 AR antagonist for binding to the same orthosteric binding site on the a 2A AR, it is possible for ligand binding to an allosteric site to appear competitive in this assay. We have previously reported that TCAs do in fact bind to the a 2A AR orthosteric site (Cottingham et al., 2011) , applying a method described by Limbird (2005) which requires the construction of competition binding curves at differing concentrations of radioligand. Here, we applied the same method for clozapine in order to confirm that the tricyclic antipsychotics are also capable of binding the orthosteric site. We obtained IC 50 to K i value ratios for clozapine from competition binding curves constructed at radioligand concentrations of 2, 4, and 8 nM (Fig. 1B) . As shown in Fig. 1C , plotting these ratios as a function of radioligand concentration (normalized to its own K i ) revealed a strong linear relationship, characteristic of binding that is truly competitive with the radioligand at the receptor orthosteric site.
In concordance, typical sigmoidal concentration-response curves were able to be constructed for chlorpromazine, clozapine, and fluphenazine (Fig. 1D) . K i values obtained from analysis of these curves are shown in Table 1 . As a group, the tricyclic antipsychotics bind the a 2A AR with stronger affinity than the TCAs (Cottingham et al., 2011 (Cottingham et al., , 2014 . To provide physiological context, Table 1 also includes reported average clinical blood plasma levels for these drugs. By comparing our experimentally-determined K i values with the clinically-relevant therapeutic levels (Baldessarini and Tarazi, 2006) , it becomes apparent that the affinity values for each of the tricyclic compounds are either well within or extremely close to the relevant therapeutic ranges. Furthermore, as also shown in Fig. 2A) . Note that NE stimulation was done in the presence of 1 mM prazosin and propranolol, to block any potential NE-induced G protein coupling to a 1 /a 2B /a 2C and b ARs, respectively. Consistent with their inability to induce G protein coupling, none of the antipsychotic compounds could drive the canonical Ga i -mediated inhibition of cAMP production, while NE, when evaluated in parallel, caused a nearly 50% inhibition of cAMP production (Fig. 2B) . As an additional measure, we elected to evaluate our selected antipsychotics for potential activation of an additional downstream effector, specifically the ERK1/2 MAP kinase cascade. Although many GPCRs elicit ERK activation through arrestins, this cascade is well-established as a readout for classical, G protein dependent signal transduction in response to a 2A AR activation by agonists (Wang et al., , 2006 . As shown in Fig. 2C , we were unable to detect any ERK1/2 activation in response to clozapine. Taken together, our data obtained using multiple independent approaches suggest that the tricyclic antipsychotic compounds tested in this study do not activate G protein-mediated signaling.
Given (Fig. 3B) . Collectively, the data presented thus far suggest that our selected tricyclic antipsychotics share the property of arrestin-biased a 2A AR agonism with the previouslyevaluated TCAs.
The tricyclic antipsychotic compounds have variable capacity
to drive a 2A AR endocytosis
Our observation of antipsychotic-induced Arr3 recruitment, along with our previous data on TCAs (Cottingham et al., 2011 (Cottingham et al., , 2014 , led us to next investigate whether acute exposure to the antipsychotics can induce a 2A AR endocytosis. As shown in Fig. 4A , immunostaining assays revealed that both chlorpromazine and clozapine drive robust a 2A AR endocytosis, indicated by the appearance of characteristic intracellular punctae containing endocytosed receptors, which were pre-labeled prior to stimulation. We further confirmed the endocytic response using cellsurface ELISA, a technique which also allowed us to quantify endocytosis by detected cell surface receptor amount following stimulation. As shown in Fig. 4B , clozapine and chlorpromazine caused approximately 40% and 30% receptor loss from the cell surface, respectively. Interestingly, although fluphenazine was found to induce a 2A AR/Arr3 interaction, and with a strength similar to chlorpromazine (Fig. 3B) , unlike chlorpromazine, it failed to induce detectable endocytosis of the receptor (Fig. 4A and B) . These data indicate that our selected antipsychotics possess differential capacities to drive a 2A AR endocytosis, and, given the comparatively weak Arr3 recruitment capacity of clozapine (Fig. 3B) , raise additional questions about the mechanism underlying the observed receptor endocytosis.
To address these questions, we further tested the ability of clozapine and chlorpromazine to drive a 2A AR endocytosis in arrestin-null (Arr2,3 -/-) MEF cells. The a 2A AR endocytic response to chlorpromazine was lost in the arrestin-null cells (Fig. 5A) , while the response to clozapine was preserved (Fig. 5B ). This finding indicates that chlorpromazine-induced a 2A AR endocytosis is arrestin-dependent, while clozapine-induced a 2A AR endocytosis is arrestin-independent. In an attempt to further clarify the mechanism underlying clozapine-driven a 2A AR endocytosis, we used chemical approaches to disrupt other potential endocytic machinery components. First, we utilized a K þ depletion method, which has been demonstrated to disrupt the formation of clathrin-coated pits at the plasma membrane (Hansen et al., 1993 ). This manipulation failed to prevent clozapine-driven a 2A AR endocytosis (Fig. 5C ). Collectively, our data indicate that clozapine binding to a 2A ARs does not engage the canonical arrestin-and clathrinmediated pathway for GPCR endocytosis. In addition to the relatively more common canonical pathway through clathrin-coated pits (Tan et al., 2004; Hanyaloglu and von Zastrow, 2008) , GPCRs can alternatively internalize through lipid rafts (Chini and Parenti, 2004; Barnett-Norris et al., 2005; Allen et al., 2007) . Therefore, we next tested whether disruption of lipid rafts by MbCD treatment could block clozapine-induced internalization of a 2A ARs. In cells treated cells with MbCD, internalization induced by clozapine stimulation was completely abolished, as revealed by immunostaining with receptor pre-labeling ( Fig. 6A and B). Meanwhile, internalization of a 2A AR induced by NE, which occurs through an arrestin-and clathrin-dependent pathway (Cottingham et al., 2011) , was not affected by MbCD treatment (Fig. 6C and D) . Blockade of clozapine-induced internalization by MbCD was also demonstrated by cell-surface ELISA method (Fig. 6E) .
We further examined colocalization of the receptor and caveolin-1 before and after clozapine stimulation. In the naïve state, there is a significant portion of a 2A ARs localized in caveolin-rich domains of the plasma membrane ( Fig. 7A and B) . Following clozapine stimulation, colocalized a 2A AR and caveolin was found within the cytoplasm (Fig. 7A and B) . Taken together, these data suggest that the clozapine-bound a 2A ARs internalize through caveolae-mediated endocytosis.
The tricyclic antipsychotic compounds display differential docking to the a 2A AR ligand-binding site in silico
To explore structural insights regarding the observed biochemical profiles of the tricyclic compounds, we conducted in silico molecular docking studies using a constructed a 2A AR homology model. The three antipsychotic compounds under evaluation in the present study were evaluate alongside the TCA DMI, which was the major subject of our previously published work. While all four tricyclic compounds docked well into the ligandbinding site, which is mainly formed by residues from transmembrane domain (TM) 3 (TM3), TM5, TM6, TM7 and the extracellular loop 2 (xl2) of a 2A AR, there are clear differences among their predicted binding modes (Fig. 8) . Each of the four compounds has a similar tricyclic core structure, but with a very different fragment (i.e., the characteristic long side chain) attached to it; the of an internal non-stimulated control (Ctl), which is set as 100% cell-surface receptor. Data are mean ± S.E. and represent n ! 5 independent replicates. *, p < 0.01 versus Ctl; **, p < 0.001 versus Ctl by unpaired Student's t-test.
value of such a fragment-centered analysis is supported by a recent review on the subject of fragment-based drug design (Wasko et al., 2015) . DMI and chlorpromazine have the most similar fragments attached, methylpropan-amine and dimethylpropan-amine, respectively, and their docked models indeed showed the same binding mode: both compounds occupied the center of the binding site, and their docked results overlaid well with each other, with the amine group forming a hydrogen bond with Asp 3.32 of TM3 (Fig. 8AeD) . The attached fragment of clozapine is a relatively bulky methylpiperazine group. Compared to the binding modes of DMI and chlorpromazine, the docked clozapine rotated away from TM3 towards TM7, with its piperazine group forming hydrophobic interactions with Phe 7.39 of TM7 (Fig. 8E and F) . Of the compounds studied, fluphenazine has the largest fragment attached. As a result, its long propylpiperazin-ethan group extended outside the ligandbinding site and formed a hydrogen bond with Glu 2.65 of TM2; its tricyclic group was pushed closer to TM5, and its trifluoromethyl group formed additional interactions with TM4 ( Fig. 8G and H) . These in silico results seem to segregate the evaluated tricyclic compounds into three distinctive modes of ligand interaction with the a 2A AR, consistent with the fact that three compounds exhibit distinct features in inducing endocytosis of the receptor. As a comparison, we also docked NE. The binding site of NE is relatively small (Fig. 8I) . Nonetheless, in addition to the hydrogenbond with Asp 3.32 of TM3, the docked NE forms multiple hydrogen bonds with Ser 5.43 and Ser 5.42 of the TM5 (Fig. 8J) . Hydrogenbonding with Ser 5.43 and Ser 5.42 has been shown in agonistbound GPCR crystal structures (Lebon et al., 2011; Warne et al., 2011; Ring et al., 2013) , and is likely responsible for the activation of G protein-dependent signaling pathways. These hydrogen bonds were not observed in the docked tricyclic compounds, which likely explains their lack of G protein activation.
Discussion
The data presented herein provide novel insights into the molecular pharmacology of an important group of therapeutics, namely the tricyclic antipsychotics. When coupled with our extensive previously-published data on the TCAs, we can begin to paint an increasingly detailed picture of how various psychopharmacological agents belonging to the tricyclic chemical class interact with a centrally-important and psychiatric diseaserelevant GPCR, namely the a 2A AR. As a group, all tricyclic compounds studied share the characteristic of acting as arrestin-biased ligands at the a 2A AR, driving Arr3 recruitment to the receptor while not stimulating any canonical heterotrimeric G protein coupling to it. However, numerous specific differences exist among the tricyclics studied in terms of the nature of Arr3 recruitment, ability to induce a 2A AR endocytosis, and mechanistic underpinnings of a 2A AR endocytosis. Furthermore, the in silico molecular modeling performed in the present study provides additional support for grouping the tricyclics based upon their molecular interactions with the a 2A AR.
Among the three antipsychotics evaluated in the present study, we have observed three different combinations of Arr3 recruitment (Fig. 3 ) and endocytic induction (Fig. 4) . Only chlorpromazine drove both robust a 2A AR/Arr3 interaction and robust receptor endocytosis. This endocytic response was further shown to be fully dependent on arrestin (Fig. 5A) . Clozapine was clearly less effective at driving the a 2A AR/Arr3 interaction, but conversely, seemed to be the most effective of the three at driving receptor endocytosis, doing so in a fully arrestin-independent fashion (Fig. 5C ). Finally, fluphenazine drove robust a 2A AR/Arr3 interaction, on par with that driven by chlorpromazine, but failed to produce a significant endocytic response for the receptor. Given the lack of endocytosis, the functional significance of the fluphenazine-induced a 2A AR/Arr3 interaction remains to be elucidated; further investigation in this regard will be a goal of future work. is set as 100% cell-surface receptor, are mean ± S.E., and represent n ¼ 14e15 independent replicates. *, p < 0.01 versus Ctl; **, p < 0.0001 versus Ctl by unpaired Student's t-test.
While fluphenazine is unique among the tricyclic compounds studied thus far in not driving any appreciable a 2A AR endocytosis, clozapine is unique among that same group in driving robust a 2A AR endocytosis not mediated by the canonical arrestin-dependent machinery for GPCRs. The three TCAs which we have previously studied (Cottingham et al., 2011 (Cottingham et al., , 2014 and chlorpromazine all drive a 2A AR endocytosis in an arrestin-mediated fashion. Clozapineinduced a 2A AR endocytosis also seems to occur independent of clathrin-coated pits (Fig. 5C) , which mediate the predominantlyengaged pathway for GPCR endocytosis (Hanyaloglu and von Zastrow, 2008) . Instead, a manipulation known to disrupt the lipid rafts completely abolished clozapine-induced internalization (Fig. 6A, B and 6E ). In addition, following clozapine exposure, internalized a 2A ARs were found to colocalize with caveolin-1 within the cytoplasm (Fig. 7A and B) . These findings indicate that clozapine induces endocytosis through machinery relying on caveolae and lipid rafts. It is worth noting that there is a significant proportion of a 2A ARs colocalized with caveolin-1 in the naïve state ( Fig. 7A and B) . It is therefore conceivable that clozapine specifically engages this pool of receptors in the lipid rafts and causes their 
internalization.
The receptor internalization driven by tricyclic compounds has the potential to play an important physiological role. In vivo, this tricyclic-induced internalization would not occur in a vacuum; rather, it would occur within the context of complex, multifactorial synapses within the CNS. Most CNS synapses, particular those of the cortical regions associated with the sophisticated cognitive processes modulated by antipsychotics, comprise multiple presynaptic terminals releasing multiple neurotransmitters, which in turn act via multiple receptors (Molinoff, 2011) . The functioning of such synapses is determined by a dynamic balance of numerous neurotransmitter/receptor interactions. Therefore, any pharmacological intervention which alters that balance has the potential to, in turn, alter synaptic function. Our data clearly establish that potential for clozapine and chlorpromazine, in the form of their ability to alter cell-surface availability of a 2A ARs by driving their internalization. Further study will obviously be required to elucidate precise effects on the relevant synapses, but it has become increasingly apparent that endocytosis of neurotransmitter receptors can have numerous functional ramifications by altering the plasma membrane localization of receptors, directing receptors into intracellular sorting pathways, and allowing for receptorinitiated signaling from endosomes (von Zastrow and Williams, 2012; Irannejad et al., 2015) .
It seems clear that, at least with respect to Arr3-recruiting and endocytic profiles when acting as direct a 2A AR ligands, the various tricyclic compounds studied to-date can be organized into three different functional groups. The first group is the most populous, comprising all three TCAs (DMI, imipramine, and amitriptyline) plus the antipsychotic chlorpromazine, and displays a profile of driving Arr3 recruitment to the a 2A AR, followed by rapid arrestindependent a 2A AR endocytosis. The second group has but a single member, the antipsychotic clozapine, and displays a profile of weakly driving Arr3 recruitment to the receptor while simultaneously driving rapid arrestin-and clathrin-independent receptor endocytosis. The third group also has but a single member, the antipsychotic fluphenazine, and displays a profile of driving robust Arr3 recruitment to the receptor with no detectable receptor endocytosis.
Our in silico modeling analysis provides structural insights into how the tricyclic ligands interact with the extracellular face of an a 2A AR homology model, and supports the existence of the same three different sub-groups of tricyclics. While the docked NE forms multiple hydrogen bonds with Ser 5.43 and Ser 5.42 of the TM5 (Fig. 8J) , which are important for G protein activation, none of the tricyclic compounds do so (Fig. 8B, D , F and H), corresponding nicely with their inability to activate heterotrimeric G proteins. Among the tricyclics, the docked models of the TCA DMI and chlorpromazine showed good overlap with each other, suggesting that they interact similarly with the a 2A AR ligand-binding pocket (Fig. 8AeD) ; this correlates with their nearly identical Arr3-recruiting and endocytic profiles. Perhaps unsurprisingly, of the selected antipsychotics, chlorpromazine is the most structurally similar to DMI; it should be noted that the other two previouslystudied TCAs also share extremely similar characteristic long side chains (Cottingham et al., 2014) . By contrast, the docked models of clozapine ( Fig. 8E and F) and fluphenazine ( Fig. 8G and H) suggest molecular interactions with the a 2A AR distinct both from each other and from the TCA/chlorpromazine group. In terms of its ability to drive a 2A AR endocytosis and its in silico interaction with the receptor, fluphenazine stands alone: it is the only tricyclic compound studied that does not drive a 2A AR endocytosis, and that displays a molecular ligand/receptor interaction extending outside of the classic ligand-binding site. Given recent and ever-expanding advances in GPCR structural determination and modeling capability (Kobilka, 2011; Shoichet and Kobilka, 2012; Costanzi, 2014) , and the great potential of fragment-based drug design for central nervous system targets (Wasko et al., 2015) , we believe our data are of great potential significance to the field. It is, of course, extremely important to note that future studies will be required to definitively establish a causal link between the varying in silico molecular interactions and the functional differences seen in a real biological system. Nevertheless, our present body of work at least establishes a clear correlation between the two that is very much worth following up on, and could have practical ramifications for future drug design.
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